KALLYOPE
Kallyope, headquartered at the Alexandria Centerยฎ for Life Science in New York City, is a biotechnology company dedicated to unlocking the therapeutic potential of the gut-brain axis. The companyโs cross-disciplinary team integrates advanced technologies in sequencing, bioinformatics, neural imaging, cellular and molecular biology, and human genetics to provide an understanding of gut-brain biology that leads to transformational therapeutics to improve human health. The companyโs founders are Charles Zuker, Ph.D., Lasker Award winner Tom Maniatis, Ph.D., and Nobel laureate Richard Axel, M.D. For more information, visit www.kallyope.com.
KALLYOPE
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2015-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.kallyope.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
479 M USD
Technology used in webpage:
LetsEncrypt Nginx Euro Amazon Amazon Virginia Region Ubuntu Nginx 1.14
Similar Organizations
Dauntless Pharmaceuticals
Dauntless Pharmaceuticals is a biotechnology company that focuses on the development of drugs.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Ocean Biomedical
Ocean Biomedical is a biotechnology company that accelerates new discoveries in the world of medicine.
PanTheryx
PanTheryx is a nutrition and biotechnology company that utilizes the cellular and biomolecular processes of bovine colostrum.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Current Advisors List
Current Employees Featured
Founder
Investors List
The Column Group
The Column Group investment in Series D - Kallyope
Euclidean Capital
Euclidean Capital investment in Series D - Kallyope
Bill Gates
Bill Gates investment in Series D - Kallyope
Casdin Capital
Casdin Capital investment in Series D - Kallyope
Polaris Partners
Polaris Partners investment in Series D - Kallyope
Tao Capital Partners
Tao Capital Partners investment in Series D - Kallyope
Two Sigma Ventures
Two Sigma Ventures investment in Series D - Kallyope
Hartford HealthCare Endowment
Hartford HealthCare Endowment investment in Series D - Kallyope
StepStone Group
StepStone Group investment in Series D - Kallyope
DNS Capital
DNS Capital investment in Series D - Kallyope
Official Site Inspections
http://www.kallyope.com Semrush global rank: 4.13 M Semrush visits lastest month: 2.91 K
- Host name: 23.185.0.2
- IP address: 23.185.0.2
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago